Altria Group, Inc.

LSE:0R31 Stock Report

Market Cap: US$93.9b

Altria Group Valuation

Is 0R31 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0R31 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0R31 ($55.53) is trading below our estimate of fair value ($130.25)

Significantly Below Fair Value: 0R31 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0R31?

Key metric: As 0R31 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0R31. This is calculated by dividing 0R31's market cap by their current earnings.
What is 0R31's PE Ratio?
PE Ratio9.1x
EarningsUS$10.26b
Market CapUS$93.88b

Price to Earnings Ratio vs Peers

How does 0R31's PE Ratio compare to its peers?

The above table shows the PE ratio for 0R31 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average16.6x
IMB Imperial Brands
9.4x0.8%UK£19.6b
DGE Diageo
17.2x3.9%UK£52.6b
ABF Associated British Foods
11.4x4.2%UK£16.6b
ITC ITC
28.4x9.6%₹5.9t
0R31 Altria Group
9.1x-4.9%US$93.9b

Price-To-Earnings vs Peers: 0R31 is good value based on its Price-To-Earnings Ratio (9.1x) compared to the peer average (16.6x).

Price to Earnings Ratio vs Industry

How does 0R31's PE Ratio compare vs other companies in the Global Tobacco Industry?

4 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0R31 9.1xIndustry Avg. 11.6xNo. of Companies6PE0816243240+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0R31 is good value based on its Price-To-Earnings Ratio (9.1x) compared to the Global Tobacco industry average (11.6x).

Price to Earnings Ratio vs Fair Ratio

What is 0R31's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0R31 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio9.1x
Fair PE Ratio18x

Price-To-Earnings vs Fair Ratio: 0R31 is good value based on its Price-To-Earnings Ratio (9.1x) compared to the estimated Fair Price-To-Earnings Ratio (18x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0R31 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$55.53
US$55.22
-0.6%
13.9%US$73.00US$42.00n/a12
Nov ’25US$54.12
US$55.14
+1.9%
14.1%US$73.00US$42.00n/a12
Oct ’25US$50.83
US$52.85
+4.0%
15.3%US$73.00US$41.00n/a12
Sep ’25US$53.51
US$50.93
-4.8%
16.3%US$73.00US$39.00n/a13
Aug ’25US$49.83
US$49.78
-0.1%
17.9%US$73.00US$37.00n/a13
Jul ’25US$45.88
US$48.16
+5.0%
18.8%US$73.00US$36.00n/a13
Jun ’25US$45.75
US$46.76
+2.2%
17.8%US$73.00US$36.50n/a14
May ’25US$43.96
US$46.71
+6.3%
17.8%US$73.00US$36.50n/a14
Apr ’25US$43.70
US$46.61
+6.7%
17.9%US$73.00US$36.10n/a14
Mar ’25US$40.92
US$46.90
+14.6%
18.2%US$73.00US$36.10n/a14
Feb ’25US$41.31
US$47.33
+14.6%
18.0%US$73.00US$36.10n/a14
Jan ’25US$40.24
US$46.67
+16.0%
15.4%US$70.00US$37.00n/a16
Dec ’24US$42.52
US$47.04
+10.6%
15.4%US$70.00US$37.00n/a16
Nov ’24US$39.99
US$47.63
+19.1%
15.3%US$70.00US$37.00US$54.1217
Oct ’24US$41.94
US$49.36
+17.7%
13.4%US$70.00US$37.00US$50.8317
Sep ’24US$44.08
US$49.54
+12.4%
13.5%US$70.00US$37.00US$53.5117
Aug ’24US$45.28
US$49.43
+9.2%
14.1%US$70.00US$37.00US$49.8317
Jul ’24US$45.28
US$49.43
+9.2%
14.1%US$70.00US$37.00US$45.8817
Jun ’24US$44.81
US$49.44
+10.3%
14.1%US$70.00US$37.00US$45.7516
May ’24US$47.61
US$50.62
+6.3%
12.6%US$70.00US$38.00US$43.9615
Apr ’24US$44.53
US$50.70
+13.9%
12.9%US$70.00US$38.00US$43.7014
Mar ’24US$46.06
US$49.80
+8.1%
14.0%US$70.00US$37.00US$40.9216
Feb ’24US$46.90
US$49.38
+5.3%
14.1%US$70.00US$37.00US$41.3116
Jan ’24US$45.55
US$49.25
+8.1%
14.1%US$68.00US$37.00US$40.2416
Dec ’23US$46.91
US$48.94
+4.3%
14.4%US$68.00US$37.00US$42.5216
Nov ’23US$46.17
US$50.15
+8.6%
15.3%US$68.00US$36.00US$39.9917

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

Bakkavor Group

UK£780.8m

Engages in the preparation and marketing of fresh prepared foods in the United Kingdom, the United States, and China.

BAKKL

UK£1.36

7D

-4.2%

1Y

54.3%

Ebro Foods

€2.5b

Operates as a food company in Spain, rest of Europe, the United States, Canada, and internationally.

0NYH

€16.02

7D

-1.4%

1Y

1.5%

Savencia

€674.0m

Produces, distributes, and markets dairy and cheese products in France, rest of Europe, and internationally.

0DTK

€50.20

7D

-2.3%

1Y

-7.0%